PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.

Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 114 results · Diabetes  · Clear
🔒 Subscribers only
AUTH/3906/5/24
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Boehringer Ingelheim
An anonymous complainant found a Jardiance (empagliflozin) case-study slide deck (“Weight and type 2 diabetes”) accessible via a URL on a Boehringer promotional website.The deck appeared to hav…
Clauses: NONE
🔒 Subscribers only
AUTH/3788/6/23
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca
A health professional complained about the “SPONSORED” section of a third-party publisher’s email newsletter. The sponsored content block read: “Sponsored: See Beyond Sugar: Using NICE NG28…
Clauses: NONE
🔒 Subscribers only
AUTH/3779/6/23
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AUTH/3779/6/23 & AUTH/3780/6/23
An anonymous, non-contactable complainant (described as a former employee) raised concerns about the promotional material approval process (PMAP) used within the Boehringer Ingelheim (BI) and Eli L…
Clauses: NONE
🔒 Subscribers only
AUTH/3846/11/23
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca breached Clauses 6.1 and 5.1 after Calquence dosing leaflet omitted monitoring caveat fo
An anonymous, contactable health professional complained about an 8-page Calquence (acalabrutinib) tablet dosing resource (GB-48523; date of preparation September 2023).Page 4 stated: “No dose ad…
Clauses: NONE
🔒 Subscribers only
AUTH/3832/10/23
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca CKD education video on SGLT2 inhibitors
An anonymous, contactable complainant challenged a ~19-minute AstraZeneca-hosted video, “Chronic Kidney Disease Management Made Simple”, on AstraZeneca’s medical platform website.The video fe…
Clauses: NONE
🔒 Subscribers only
AUTH/3853/11/23
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
A. Menarini breached Clause 26.1 after third-party X post showed “Invokana canagliflozin tablets” at
A member of the public complained about an X (formerly Twitter) post showing a panoramic photo of a diabetes conference exhibition hall.In the foreground, A. Menarini’s exhibition stand was visib…
Clauses: NONE
🔒 Subscribers only
AUTH/3684/8/22
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Bayer breached ABPI Code after US Kerendia DTC
A contactable complainant (healthcare communications agency employee) complained about a Kerendia (finerenone) banner advertisement appearing on MailOnline (a UK news website with a .co.uk URL).The…
Clauses: NONE
🔒 Subscribers only
AUTH/3601/1/22
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Boehringer Ingelheim
A concerned health professional complained about a dynamic digital banner advertisement for Trajenta (linagliptin) by Boehringer Ingelheim Limited.The banner included the claim: “Unique convenien…
Clauses: NONE
🔒 Subscribers only
AUTH/3599/1/22
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca employee’s LinkedIn ‘like’ and comment held to be POM advertising to the public (AUTH/35
A hospital consultant complained about two LinkedIn items involving an AstraZeneca employee: (1) the employee’s own post about a blood pressure (BP) study; and (2) the employee ‘liking’ and c…
Clauses: NONE
🔒 Subscribers only
AUTH/3661/6/22
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca breached Clause 8.1 over Forxiga website certification differences between desktop and m
An anonymous, contactable health professional complained about certification of the Forxiga (dapagliflozin) diabetes webpage on www.forxiga.co.uk.The complainant alleged the desktop and mobile vers…
Clauses: NONE
🔒 Subscribers only
AUTH/3685/8/22
HCP Hospitality & Meetings Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sandoz
A health professional complained after patients reported Sandoz had stopped providing an Omnitrope insulated cool bag (with six cool packs) previously included in a “starter pack”/package deal.…
Clauses: NONE
🔒 Subscribers only
AUTH/3468/2/21
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi breached ABPI Code after uncertified internal email to salesforce about Toujeo patient materi
An anonymous, non-contactable complainant (describing themselves as a Sanofi employee) complained about an email sent to the salesforce titled “Toujeo news – Patient material & Digital camp…
Clauses: NONE
🔒 Subscribers only
AUTH/3471/2/21
HCP Hospitality & Meetings Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
A contactable complainant (described as a nurse) said that towards the end of 2020 a Sanofi representative emailed “Toujeo Coach” webinar invitations.The complainant alleged they had not given …
Clauses: NONE
🔒 Subscribers only
AUTH/3500/4/21
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Employee complaint about representative training at Sanofi (No breach)
An anonymous, non-contactable employee complained about the quality of training provided when joining Sanofi as a diabetes representative.The complainant alleged that much of the training had been …
Clauses: NONE
🔒 Subscribers only
AUTH/3454/1/21
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (describing themselves as a Sanofi representative) raised concerns about briefing materials for Toujeo Coach, a patient support programme for adults prescr…
Clauses: NONE
🔒 Subscribers only
AUTH/3455/1/21
HCP Hospitality & Meetings Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi breached ABPI Code over misleading “fewer prescriptions” claim for Toujeo DoubleStar in virtu
An anonymous, non-contactable complainant alleged a Sanofi representative, in a virtual promotional meeting for Toujeo (insulin glargine 300 units/ml), claimed Toujeo DoubleStar resulted in “fewe…
Clauses: NONE
🔒 Subscribers only
AUTH/3481/3/21
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (described as a Sanofi employee) raised concerns about internal communications relating to Suliqua (insulin glargine with lixisenatide).An internal email c…
Clauses: NONE
🔒 Subscribers only
AUTH/3486/3/21
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (self-described health professional) complained about alleged off-licence promotion of Suliqua (insulin glargine + lixisenatide) by Sanofi.The complainant …
Clauses: NONE
🔒 Subscribers only
AUTH/3491/3/21
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (self-described health professional) alleged off-licence promotion of Suliqua (insulin glargine/lixisenatide) by Sanofi.The complainant said a diabetes nur…
Clauses: NONE
🔒 Subscribers only
AUTH/3549/7/21
HCP Hospitality & Meetings Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi Lantus rebates
An anonymous complainant (described as a Sanofi employee) alleged Sanofi had a strategy of offering Lantus (insulin glargine) rebates to prevent uptake of biosimilar insulin, which the complainant …
Clauses: NONE
🔒 Subscribers only
AUTH/3560/9/21
Data & Publications Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Anonymous health professional complaint about pressure to sign up to diabetes review service (No bre
An anonymous, non-contactable complainant (describing themself as a nurse) alleged a named Sanofi diabetes representative (account executive) repeatedly asked them to sign up to a diabetes review s…
Clauses: NONE
🔒 Subscribers only
AUTH/3559/9/21
HCP Hospitality & Meetings Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
An anonymous complainant (describing themselves as a Sanofi employee) raised concerns about a business unit’s push to develop health professional “advocates” for Toujeo (insulin glargine) and…
Clauses: NONE
🔒 Subscribers only
AUTH/3576/11/21
HCP Hospitality & Meetings Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Novo Nordisk webinar invite
A health professional complained about an email invitation advertising a webinar on type 2 diabetes and managing the post-COVID backlog.The webinar was organised and fully funded by Novo Nordisk; N…
Clauses: NONE
🔒 Subscribers only
AUTH/3578/11/21
HCP Hospitality & Meetings Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca internal training role-plays with real HCPs
An AstraZeneca employee complained about internal “selling” training (Nov 2021) delivered with a third-party provider using real health professionals (HCPs) for simulated meetings/role-plays.Pa…
Clauses: NONE
1 2 3 4 Next → Page 1 of 5 — 114 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews